The Joint Corp. (JYNT)
| Market Cap | 111.97M -26.3% |
| Revenue (ttm) | 58.55M +9.0% |
| Net Income | 3.80M |
| EPS | 0.26 |
| Shares Out | 13.61M |
| PE Ratio | 31.66 |
| Forward PE | 14.87 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 62,108 |
| Open | 8.23 |
| Previous Close | 8.29 |
| Day's Range | 8.07 - 8.24 |
| 52-Week Range | 7.50 - 10.67 |
| Beta | 1.06 |
| Analysts | Hold |
| Price Target | 10.00 (+21.51%) |
| Est. Earnings | Nov 5, 2026 |
About JYNT
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Financial Performance
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for JYNT stock is "Hold." The 12-month stock price target is $10.0, which is an increase of 21.51% from the latest price.
News
The Joint Earnings Call Transcript: Q2 2026
Revenue grew 14% year-over-year to $15.2M, with adjusted EBITDA up $1.4M and net income rising to $653,000. The transition to a capital-light franchisor model is nearly complete, driving improved margins, cash flow, and patient retention. Full-year guidance is reiterated.
The Joint Earnings release: Q2 2026
The Joint released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
The Joint Slides: Q2 2026
The Joint has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
The Joint Quarterly report: Q2 2026
The Joint has published its Q2 2026 quarterly earnings report on August 6, 2026.
The Joint Chiropractic Earns Entrepreneur Recognition as a Premier Multi-Unit Franchise Investment
Top Brands for Multi-Unit Owners honor underscores continued momentum of nation's largest chiropractic franchise as experienced operators seek scalable healthcare investments SCOTTSDALE, Ariz., July 3...
The Joint Corp. to Report 2026 Second Quarter Results on Thursday, August 6 and Host Conference Call and Webcast
SCOTTSDALE, Ariz., July 23, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, announced it will re...
The Joint Chiropractic Expands to 44th State with Opening of Rhode Island Clinic
Military spouse and military officer, multi-unit franchise owners Sarah and Yosef Perfido lead brand's entry into Rhode Island, highlighting continued growth of nation's largest chiropractic network S...
The Joint Corp. Announces Milind Pant Elected as Director
- Global Executive with Extensive Digital and International Franchise-Led Growth Experience - SCOTTSDALE, Ariz., May 21, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest f...
The Joint Transcript: AGM 2026
The meeting confirmed a quorum, elected seven directors, approved executive compensation and auditor appointment, and acknowledged two board retirements. No shareholder questions were received, and final voting results will be filed with the SEC.
The Joint Earnings Call Transcript: Q1 2026
Revenue grew 13% year-over-year to $14.8M, with adjusted EBITDA from continuing operations up sharply and net income turning positive. Major refranchising is nearly complete, transforming the business into a pure-play franchisor, with improved profitability and strong cash flow supporting share repurchases.
The Joint Earnings release: Q1 2026
The Joint released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
The Joint Slides: Q1 2026
The Joint has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
The Joint Quarterly report: Q1 2026
The Joint has published its Q1 2026 quarterly earnings report on May 7, 2026.
The Joint Corp. Reports First Quarter 2026 Financial Results
- First Quarter Revenues Grew 13%, Net Income Rose 34% and Adjusted EBITDA Increased 22% Year over Year - - Repurchased $1.1 Million of Shares - SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- The...
Joint Corp. to sell 45 corporate managed clinics to Elite Chiro for $2.3M
Joint Corp. (JYNT) announced that it has signed an asset purchase agreement effective on April 20 for the sale of 45 corporate managed clinics in Southern California to Elite Chiro…
The Joint Corp. Signs Asset Purchase Agreement to Sell 45 Corporate-Owned Clinics in Southern California
- Effectively Positions The Joint as a Pure-play Franchisor - SCOTTSDALE, Ariz., April 27, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) (the “Company”), the nation's largest franchisor of c...
The Joint Chiropractic® Names Michelle Reap as Director of Franchise Development
Experienced franchise executive joins the nation's largest chiropractic care network to align its next phase of growth SCOTTSDALE, Ariz., April 14, 2026 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT),...
The Joint Chiropractic and Subaru of Utah Partner to Bring Chiropractic Care to over 275 Employees
New agreement offers Miller Subaru employees in Utah access to preferred pricing on The Joint's already affordable care model across participating locations, expanding their existing wellness offering...
The Joint Proxy statement: Proxy filing
The Joint filed a proxy statement on April 7, 2026, providing details for shareholder voting and corporate governance matters.
The Joint Proxy statement: Proxy filing
The Joint filed a proxy statement on April 7, 2026, providing details for shareholder voting and corporate governance matters.
Joint Corp. price target lowered to $12 from $14 at Roth Capital
Roth Capital lowered the firm’s price target on Joint Corp. (JYNT) to $12 from $14 and keeps a Buy rating on the shares. The company’s Q4 results exceeded estimates while…
The Joint Earnings Call Transcript: Q4 2025
Revenue and adjusted EBITDA grew in Q4 2025, driven by cost optimization and refranchising progress. Marketing and pricing initiatives are underway to boost new patient acquisition, with 2026 guidance projecting stable to modestly higher sales and profitability.
The Joint Annual report: Q4 2025
The Joint has published its Q4 2025 annual report on March 12, 2026.
The Joint Earnings release: Q4 2025
The Joint released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
The Joint Slides: Q4 2025
The Joint has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.